Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126292011 | 12629201 | 1 | I | 20100505 | 20100506 | 20160808 | 20160808 | EXP | GB-ASTELLAS-2010001815 | ASTELLAS | 65.74 | YR | M | Y | 0.00000 | 20160808 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126292011 | 12629201 | 1 | PS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | Oral | 0 | 1 | DF | FORMULATION UNKNOWN | QD | |||||||
| 126292011 | 12629201 | 2 | SS | PLACEBO | UNSPECIFIED INGREDIENT | 1 | 0 | FORMULATION UNKNOWN | |||||||||||
| 126292011 | 12629201 | 3 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 200 | MG | U | 0 | 2 | MG | FORMULATION UNKNOWN | BID | ||||
| 126292011 | 12629201 | 4 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 200 | MG | U | 0 | 1 | MG | FORMULATION UNKNOWN | QD | ||||
| 126292011 | 12629201 | 5 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 200 | MG | U | 0 | 4 | MG | FORMULATION UNKNOWN | BID | ||||
| 126292011 | 12629201 | 6 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 200 | MG | U | 0 | 8 | MG | FORMULATION UNKNOWN | BID | ||||
| 126292011 | 12629201 | 7 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 200 | MG | U | 0 | 4 | MG | FORMULATION UNKNOWN | BID | ||||
| 126292011 | 12629201 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | U | 0 | 20 | MG | FORMULATION UNKNOWN | QD | ||||||
| 126292011 | 12629201 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | U | 0 | 20 | MG | FORMULATION UNKNOWN | QD | ||||||
| 126292011 | 12629201 | 10 | C | DALTEPARIN /01708302/ | 2 | Subcutaneous | U | 0 | 18000 | IU | FORMULATION UNKNOWN | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126292011 | 12629201 | 1 | Non-small cell lung cancer |
| 126292011 | 12629201 | 2 | Metastases to central nervous system |
| 126292011 | 12629201 | 3 | Metastases to central nervous system |
| 126292011 | 12629201 | 8 | Dyspepsia |
| 126292011 | 12629201 | 10 | Pulmonary embolism |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126292011 | 12629201 | LT |
| 126292011 | 12629201 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126292011 | 12629201 | Pneumonia | |
| 126292011 | 12629201 | Pulmonary embolism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126292011 | 12629201 | 1 | 20100419 | 0 | ||
| 126292011 | 12629201 | 3 | 20100317 | 20100505 | 0 | |
| 126292011 | 12629201 | 4 | 20100514 | 0 | ||
| 126292011 | 12629201 | 5 | 201004 | 20100904 | 0 | |
| 126292011 | 12629201 | 6 | 20100904 | 20100908 | 0 | |
| 126292011 | 12629201 | 7 | 20100904 | 0 | ||
| 126292011 | 12629201 | 8 | 200812 | 0 | ||
| 126292011 | 12629201 | 9 | 20100506 | 0 | ||
| 126292011 | 12629201 | 10 | 20100505 | 0 |